Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Actelion’s MS candidate shows promise

August 2, 2011 Research and Development Actelion, MS

Actelion’s prospective multiple sclerosis pill ponesimod has cheered the company by meeting its primary endpoint in a phase IIb trial. …
News

Teva’s MS treatment disappoints

August 2, 2011 Research and Development, Sales and Marketing Laquinimod, MS, Teva

Teva and Active Biotech’s oral MS drug laquinimod has failed to meet its primary endpoint in a phase III trial. …
News

Witty backs Britain as manufacturing, R&D location

July 29, 2011 Manufacturing and Production, Research and Development GSK

GlaxoSmithKline chief executive Andrew Witty has promised to expand operations in the UK in both manufacturing and R&D, saying that …
News
GlaxoSmithKline

GSK sales down on Avandia and pandemic products

July 27, 2011 Research and Development, Sales and Marketing GSK

GlaxoSmithKline has posted a slide in revenue for the second quarter, but is buoyed by strong underlying growth. Sales were …
News

Contract research news in brief

July 27, 2011 Research and Development research and development news

PPD plays down sell-off rumours, Icon sees a steep profit decline, plus updates from Beaufort, PharmaNet, ClinStar and Biofocus/IMD. PPD …
News

BMS makes $325m biotech acquisition

July 25, 2011 Research and Development, Sales and Marketing BMS, biotech, research and development news

Bristol-Myers Squibb is to plug gaps in its pipeline by buying private biotech company Amira Pharmaceuticals for $325 million in …
News

Sanofi bags GSK’s Anne Whitaker for US role

July 25, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Sanofi has appointed Anne Whitaker president of its US pharmaceutical operations. She joins the company from GlaxoSmithKline, where she served …
Appointment
Eli Lilly & Co

Lilly presents data on failed Alzheimer’s candidate

July 21, 2011 Research and Development Alzheimer's disease, lilly, research and development news, semagacestat

Lilly has presented a review of data from semagacestat, the Alzheimer’s drug it dropped last year after disappointing results. Phase …
News

Analysis paralysis – how to get the true measure of clinical trials

July 20, 2011 Research and Development Les Rose, clinical trials

The great physicist Lord Kelvin famously said: “When you can measure what you are speaking about, and express it in …
Feature

Future of AZ-BMS diabetes drug in doubt

July 20, 2011 Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes, research and development news

A US advisory committee has rejected an investigational compound for type II diabetes sufferers, throwing its future into doubt. Dapagliflozin, …
News

Contract research news in brief

July 20, 2011 Research and Development research and development news

M&A abounds in the CRO sector with INC completing its purchase of Kendle, inVentiv snappig up Pharmanet and ICON buying …
News
ASCO 2011

ASCO 2011: news from the front line against cancer

July 18, 2011 Research and Development ASCO, Cancer, oncology

Pharmafocus presents selected highlights from the American Society of Clinical Oncology’s annual meeting in Chicago, beginning with non-small cell lung …
Feature

Lophius Biosciences expands management team

July 15, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

German biotech Lophius Biosciences has made six senior management appointments ahead of a planned 2012 market entry move. The Regensburg-based …
Appointment

France cleans up regulation – and restricts pharma role

July 14, 2011 Research and Development, Sales and Marketing France, Mediator, Servier, pharmacovigilance, research and development news

France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …
News

Paul Barrow joins CiToxLAB

July 14, 2011 Research and Development appointment, research and development

French CRO CiToxLAB has appointed Paul Barrow as director of scientific projects and client consulting. He joins the Evreux-based company, …
Appointment
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026